These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9833260)

  • 61. [Vertical HBV transmission in Jerusalem in the vaccine era].
    Michaiel R; Margalit RC; Shteyer E; Ashur Y; Safadi R
    Harefuah; 2012 Dec; 151(12):671-4, 722, 721. PubMed ID: 23330257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Does migration from high and intermediate endemic regions increase the prevalence of hepatitis B infection in Germany?].
    Marschall T; Krämer A; Prüfer-Krämer L; Mikolajczyk R; Kretzschmar M
    Dtsch Med Wochenschr; 2005 Dec; 130(48):2753-8. PubMed ID: 16307403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patterns of hepatitis B infection in Egyptian children in the era of obligatory hepatitis B vaccination.
    El-Raziky MS; El-Hawary MA; Salama KM; El-Hennawy AM; Helmy HM; Fahmy ME; Hassanin FM; El-Karaksy HM
    Arab J Gastroenterol; 2012 Mar; 13(1):1-3. PubMed ID: 22560816
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Current hepatitis B epidemiology in Germany].
    Kralj N; Hofmann F; Michaelis M; Berthold H
    Gesundheitswesen; 1998 Jul; 60(7):450-5. PubMed ID: 9738355
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chronic hepatitis virus infection in children.
    Chang MH
    J Gastroenterol Hepatol; 1998 May; 13(5):541-8. PubMed ID: 9641657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 68. World-wide control of hepatitis B.
    Maynard JE
    Int J Epidemiol; 1984 Dec; 13(4):406-7. PubMed ID: 6240473
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece.
    Gogos CA; Fouka KP; Nikiforidis G; Avgeridis K; Sakellaropoulos G; Bassaris H; Maniatis A; Skoutelis A
    Eur J Epidemiol; 2003; 18(6):551-7. PubMed ID: 12908721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinico-epidemiology of hepatitis B viral infection in Northeastern Thailand.
    Chunlertrith K; Sukeepaisarnjaroen W; Mairiang P; Urwijitaroon Y; Takase K; Yamauchi T; Yoshimura H; Tameda Y
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):37-40. PubMed ID: 11023062
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Basic and clinical aspects of hepatitis virus carriers].
    Shimoyama R; Sekiguchi S
    Hokkaido Igaku Zasshi; 1996 Jul; 71(4):427-48. PubMed ID: 8809569
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatitis B in India: a review of disease epidemiology.
    Lodha R; Jain Y; Anand K; Kabra SK; Pandav CS
    Indian Pediatr; 2001 Apr; 38(4):349-71. PubMed ID: 11313505
    [No Abstract]   [Full Text] [Related]  

  • 75. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa.
    Kiire CF
    Gut; 1996; 38 Suppl 2(Suppl 2):S5-12. PubMed ID: 8786055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Seroepidemiological study for HBV markers and anti-delta in Kenya.
    Okoth FA; Kobayashi M; Kaptich DC; Kaiguri PM; Tukei PM; Takayanagi T; Yamanaka T
    East Afr Med J; 1991 Jul; 68(7):515-25. PubMed ID: 1756703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic hepatitis B: current epidemiology in the Americas and implications for management.
    Gish RG; Gadano AC
    J Viral Hepat; 2006 Dec; 13(12):787-98. PubMed ID: 17109678
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.
    Chenari M; Norouzi M; Ghalichi L; Rezaee A; Yari A; Alavian SM; Jazayeri SM
    J Med Virol; 2014 Nov; 86(11):1861-7. PubMed ID: 25132488
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nationwide vaccination: a success story in Taiwan.
    Huang K; Lin S
    Vaccine; 2000 Feb; 18 Suppl 1():S35-8. PubMed ID: 10683542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Characteristics of patients with chronic hepatitis B virus infection. analysis of a series of 474 patients].
    Gómez Rodríguez R; Guardiola Arévalo A; Gómez Moreno AZ; García Vela A; Gómez Hernando C; Rodríguez Merlo R; Sánchez Ruano JJ; de la Cruz Pérez G
    Gastroenterol Hepatol; 2013 Apr; 36(4):243-53. PubMed ID: 23414836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.